<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36964531</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1546-0096</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>24</Day></PubDate></JournalIssue><Title>Pediatric rheumatology online journal</Title><ISOAbbreviation>Pediatr Rheumatol Online J</ISOAbbreviation></Journal><ArticleTitle>Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>28</StartPage><MedlinePgn>28</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">28</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12969-023-00806-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lupus nephritis (LN) is a crucial organ involvement in systemic lupus erythematosus (SLE). Patients with LN have higher morbidity and mortality rates than those without. Among all patients with LN, 20-40% had delayed onset, but the data for patients with juvenile-onset SLE (jSLE), who have a higher percentage of LN than patients with adult-onset SLE (aSLE), were limited. This study aimed to determine the risk factors for subsequent LN in patients with jSLE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study was conducted between 2008 and 2018 in a single tertiary medical centre. Patients with diagnosed jSLE were reviewed. We investigated those without LN at diagnosis and whether they developed LN afterward. The primary outcome was the development of subsequent LN. Clinical manifestations at diagnosis, serial laboratory data, and treatments were reviewed during follow-up periods.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 48 patients with jSLE without initial LN, 20 developed subsequent LN later (Group 1), whereas 28 remained free of LN (Group 2). There was no difference in the percentage of initial manifestations except for more discoid rashes in Group 2 patients. In the Cox regression model, elevated average anti-double-stranded DNA (dsDNA) antibody, low average serum complements, and high average erythrocyte sedimentation rate (ESR) levels during follow-up were predictors of subsequent LN. After adjusting for these factors in multivariable analyses, only high average anti-dsDNA antibody and high average ESR levels remained predictive of subsequent LN. For every 100&#xa0;IU/ml increase in anti-dsDNA antibody, the risk for subsequent LN in jSLE increases by 1.29 times (hazard ratio&#x2009;=&#x2009;1.29, 95% confidence interval 1.055-1.573).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Persistently high anti-dsDNA antibody and ESR levels during the follow-up period were risk factors for subsequent LN in patients with jSLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Tzu-Chuan</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yao-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li-Chieh</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jyh-Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hsin-Hui</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yu-Tsan</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ya-Chiao</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0001-9775-5538</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan. ychu0407@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. ychu0407@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Bor-Luen</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National Taiwan University Hospital, No. 8 Chung-Shan South Road, Taipei, 100, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Rheumatol Online J</MedlineTA><NlmUniqueID>101248897</NlmUniqueID><ISSNLinking>1546-0096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-dsDNA antibody</Keyword><Keyword MajorTopicYN="N">Erythrocyte sedimentation rate</Keyword><Keyword MajorTopicYN="N">Juvenile-onset systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Subsequent lupus nephritis</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36964531</ArticleId><ArticleId IdType="pmc">PMC10039593</ArticleId><ArticleId IdType="doi">10.1186/s12969-023-00806-x</ArticleId><ArticleId IdType="pii">10.1186/s12969-023-00806-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lerang K, et al. Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study. Lupus. 2014;23(14):1546&#x2013;1552. doi: 10.1177/0961203314551083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314551083</ArticleId><ArticleId IdType="pubmed">25209070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DYH, et al. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant. 2012;27(8):3248&#x2013;3254. doi: 10.1093/ndt/gfs073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfs073</ArticleId><ArticleId IdType="pubmed">22523116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernatsky S, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550&#x2013;2557. doi: 10.1002/art.21955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21955</ArticleId><ArticleId IdType="pubmed">16868977</ArticleId></ArticleIdList></Reference><Reference><Citation>Faurschou M, et al. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) 2010;62(6):873&#x2013;880. doi: 10.1002/acr.20116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20116</ArticleId><ArticleId IdType="pubmed">20191478</ArticleId></ArticleIdList></Reference><Reference><Citation>Galindo-Izquierdo M, et al. Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER) Medicine (Baltimore) 2016;95(9):e2891. doi: 10.1097/MD.0000000000002891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002891</ArticleId><ArticleId IdType="pmc">PMC4782862</ArticleId><ArticleId IdType="pubmed">26945378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med. 1996;156(12):1337&#x2013;1344. doi: 10.1001/archinte.1996.00440110109015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1996.00440110109015</ArticleId><ArticleId IdType="pubmed">8651844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakes RW, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 2012;64(2):159&#x2013;168. doi: 10.1002/acr.20683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20683</ArticleId><ArticleId IdType="pubmed">22052624</ArticleId></ArticleIdList></Reference><Reference><Citation>Thumboo J, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum. 2001;45(6):494&#x2013;500. doi: 10.1002/1529-0131(200112)45:6&lt;494::AID-ART374&gt;3.0.CO;2-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200112)45:6&lt;494::AID-ART374&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pubmed">11762683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29(9):1011&#x2013;1020. doi: 10.1177/0961203320932219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320932219</ArticleId><ArticleId IdType="pmc">PMC7425376</ArticleId><ArticleId IdType="pubmed">32571142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkinson ND, et al. Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis. 2000;59(2):116&#x2013;119. doi: 10.1136/ard.59.2.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.59.2.116</ArticleId><ArticleId IdType="pmc">PMC1753068</ArticleId><ArticleId IdType="pubmed">10666166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastian H.M, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002;11(3):152&#x2013;60. doi: 10.1191/0961203302lu158oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203302lu158oa</ArticleId><ArticleId IdType="pubmed">12004788</ArticleId></ArticleIdList></Reference><Reference><Citation>Seligman VA, et al. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med. 2002;112(9):726&#x2013;729. doi: 10.1016/S0002-9343(02)01118-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(02)01118-X</ArticleId><ArticleId IdType="pubmed">12079714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano M, et al. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan. Lupus. 2019;28(9):1062&#x2013;1073. doi: 10.1177/0961203319860200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319860200</ArticleId><ArticleId IdType="pmc">PMC6681441</ArticleId><ArticleId IdType="pubmed">31296139</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela D-C, et al. Delayed lupus nephritis. Ann Rheum Dis. 2008;67(7):1044&#x2013;1046. doi: 10.1136/ard.2008.088740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2008.088740</ArticleId><ArticleId IdType="pubmed">18413438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinose K, et al. Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort. Arthritis Res Ther. 2020;22(1):175. doi: 10.1186/s13075-020-02271-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02271-3</ArticleId><ArticleId IdType="pmc">PMC7374914</ArticleId><ArticleId IdType="pubmed">32698892</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon SJ, et al. Predictors of chronic kidney disease in Korean patients with lupus nephritis. J Rheumatol. 2011;38(12):2588&#x2013;2597. doi: 10.3899/jrheum.110363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.110363</ArticleId><ArticleId IdType="pubmed">21965650</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JL, Yao TC, See LC. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol. 2004;22(6):776&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">15638056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr T, D&#xe9;rfalvi B, Gy&#x151;ri N, Sz&#xe1;nt&#xf3; A, Siminszky Z, Malik A, et al. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus. 2015;24(8):796&#x2013;803. doi: 10.1177/0961203314563817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314563817</ArticleId><ArticleId IdType="pubmed">25516474</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader-Meunier B, et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr. 2005;146(5):648&#x2013;653. doi: 10.1016/j.jpeds.2004.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2004.12.045</ArticleId><ArticleId IdType="pubmed">15870669</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral B, et al. A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology. 2014;53(6):1130&#x2013;1135. doi: 10.1093/rheumatology/ket488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket488</ArticleId><ArticleId IdType="pubmed">24505121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraki LT, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008;152(4):550&#x2013;556. doi: 10.1016/j.jpeds.2007.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2007.09.019</ArticleId><ArticleId IdType="pubmed">18346514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sule SD, et al. Predictors of kidney disease in a cohort of pediatric patients with lupus. Lupus. 2015;24(8):862&#x2013;868. doi: 10.1177/0961203315570162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315570162</ArticleId><ArticleId IdType="pmc">PMC4466076</ArticleId><ArticleId IdType="pubmed">25680740</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker LB, et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995;34(9):866&#x2013;872. doi: 10.1093/rheumatology/34.9.866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/34.9.866</ArticleId><ArticleId IdType="pubmed">7582729</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner HI, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556&#x2013;562. doi: 10.1002/art.23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23204</ArticleId><ArticleId IdType="pubmed">18240232</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson L, et al. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum. 2012;64(7):2356&#x2013;2365. doi: 10.1002/art.34410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34410</ArticleId><ArticleId IdType="pubmed">22294381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooley MA, Aranow C, Ginzler EM. Review of ACR renal criteria in systemic lupus erythematosus. Lupus. 2004;13(11):857&#x2013;860. doi: 10.1191/0961203304lu2023oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203304lu2023oa</ArticleId><ArticleId IdType="pubmed">15580982</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung YY, et al. Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis. Rheumatology (Oxford) 2007;46(4):649&#x2013;652. doi: 10.1093/rheumatology/kel360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel360</ArticleId><ArticleId IdType="pubmed">17065189</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz GJ, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629&#x2013;637. doi: 10.1681/ASN.2008030287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008030287</ArticleId><ArticleId IdType="pmc">PMC2653687</ArticleId><ArticleId IdType="pubmed">19158356</ArticleId></ArticleIdList></Reference><Reference><Citation>Staples A, et al. Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol. 2010;25(11):2321&#x2013;2326. doi: 10.1007/s00467-010-1598-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-010-1598-7</ArticleId><ArticleId IdType="pubmed">20652327</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247&#x2013;254. doi: 10.7326/0003-4819-145-4-200608150-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-145-4-200608150-00004</ArticleId><ArticleId IdType="pubmed">16908915</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EMD, et al. Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. Lupus. 2018;27(13):2020&#x2013;2028. doi: 10.1177/0961203318801526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318801526</ArticleId><ArticleId IdType="pubmed">30246602</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bavel CC, et al. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 2008;58(7):1892&#x2013;1899. doi: 10.1002/art.23626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23626</ArticleId><ArticleId IdType="pubmed">18576314</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung S, Chan TM. Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies. Front Immunol. 2015;6:475. doi: 10.3389/fimmu.2015.00475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00475</ArticleId><ArticleId IdType="pmc">PMC4569852</ArticleId><ArticleId IdType="pubmed">26441980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung S, et al. Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-&#x3b2;1 and collagen synthesis. J Autoimmun. 2015;58:111&#x2013;122. doi: 10.1016/j.jaut.2015.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.01.008</ArticleId><ArticleId IdType="pubmed">25666976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mjelle JE, et al. Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens. Autoimmunity. 2011;44(5):373&#x2013;383. doi: 10.3109/08916934.2010.541170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2010.541170</ArticleId><ArticleId IdType="pubmed">21244336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefkowith JB, et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Investig. 1996;98(6):1373&#x2013;1380. doi: 10.1172/JCI118924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118924</ArticleId><ArticleId IdType="pmc">PMC507563</ArticleId><ArticleId IdType="pubmed">8823302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaaji M, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int. 2007;71(7):664&#x2013;672. doi: 10.1038/sj.ki.5002133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002133</ArticleId><ArticleId IdType="pubmed">17332738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho A, et al. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2342&#x2013;2349. doi: 10.1002/1529-0131(200110)44:10&lt;2342::AID-ART397&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)44:10&lt;2342::AID-ART397&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">11665975</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris A, et al. Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review. Autoimmun Rev. 2016;15(7):656&#x2013;63. doi: 10.1016/j.autrev.2016.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.02.019</ArticleId><ArticleId IdType="pubmed">26921641</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, et al. Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective Study. J Rheumatol. 2009;36(11):2476&#x2013;2480. doi: 10.3899/jrheum.090019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.090019</ArticleId><ArticleId IdType="pubmed">19833757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastian HM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) 2007;46(4):683&#x2013;689. doi: 10.1093/rheumatology/kel347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel347</ArticleId><ArticleId IdType="pubmed">17132694</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanha N, et al. Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus. J Rheumatol. 2018;45(7):934&#x2013;941. doi: 10.3899/jrheum.170933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.170933</ArticleId><ArticleId IdType="pubmed">29657143</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba P, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis. 2003;62(6):556&#x2013;560. doi: 10.1136/ard.62.6.556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.62.6.556</ArticleId><ArticleId IdType="pmc">PMC1754557</ArticleId><ArticleId IdType="pubmed">12759294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon OC, et al. Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus. Semin Arthritis Rheum. 2018;48(3):462&#x2013;466. doi: 10.1016/j.semarthrit.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2018.02.012</ArticleId><ArticleId IdType="pubmed">29566965</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb R, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis. 2011;70(1):151&#x2013;156. doi: 10.1136/ard.2010.141697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.141697</ArticleId><ArticleId IdType="pmc">PMC3034281</ArticleId><ArticleId IdType="pubmed">20881011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina R, Brunner HI. Update on differences between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Res Ther. 2013;15(4):218. doi: 10.1186/ar4256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4256</ArticleId><ArticleId IdType="pmc">PMC3978647</ArticleId><ArticleId IdType="pubmed">23998441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho A, et al. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2350&#x2013;2357. doi: 10.1002/1529-0131(200110)44:10&lt;2350::AID-ART398&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)44:10&lt;2350::AID-ART398&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">11665976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Anders H-J. The Pathogenesis of Lupus Nephritis. J Am Soc Nephrol. 2013;24(9):1357&#x2013;1366. doi: 10.1681/ASN.2013010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013010026</ArticleId><ArticleId IdType="pmc">PMC3752952</ArticleId><ArticleId IdType="pubmed">23929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011;13(6):250. doi: 10.1186/ar3528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3528</ArticleId><ArticleId IdType="pmc">PMC3334648</ArticleId><ArticleId IdType="pubmed">22192660</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, et al. Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Front Immunol. 2018;9:1433. doi: 10.3389/fimmu.2018.01433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01433</ArticleId><ArticleId IdType="pmc">PMC6023961</ArticleId><ArticleId IdType="pubmed">29988342</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, et al. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. Lupus. 2015;24(12):1342&#x2013;1349. doi: 10.1177/0961203315591024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315591024</ArticleId><ArticleId IdType="pubmed">26085595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed DF, et al. Juvenile lupus: Different clinical and serological presentations compared to adult lupus in Egypt. The Egyptian Rheumatologist. 2018;40(1):55&#x2013;58. doi: 10.1016/j.ejr.2017.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2017.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, et al. Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity. Lupus. 2013;22(8):827&#x2013;834. doi: 10.1177/0961203313492578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313492578</ArticleId><ArticleId IdType="pmc">PMC3703841</ArticleId><ArticleId IdType="pubmed">23761098</ArticleId></ArticleIdList></Reference><Reference><Citation>Vil&#xe1; L.M, et al. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol. 2005;32(11):2150&#x2013;2155.</Citation><ArticleIdList><ArticleId IdType="pubmed">16265693</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessler B.J, et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005;52(5):1473&#x2013;80. doi: 10.1002/art.21039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21039</ArticleId><ArticleId IdType="pubmed">15880829</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, et al. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009;61(6):830&#x2013;839. doi: 10.1002/art.24538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24538</ArticleId><ArticleId IdType="pmc">PMC2898742</ArticleId><ArticleId IdType="pubmed">19479701</ArticleId></ArticleIdList></Reference><Reference><Citation>To CH, et al. Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis. Lupus. 2009;18(14):1267&#x2013;1275. doi: 10.1177/0961203309345767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345767</ArticleId><ArticleId IdType="pubmed">19861343</ArticleId></ArticleIdList></Reference><Reference><Citation>Skare TL, et al. Prognosis of patients with systemic lupus erythematosus and discoid lesions. An Bras Dermatol. 2013;88(5):755&#x2013;758. doi: 10.1590/abd1806-4841.20132042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/abd1806-4841.20132042</ArticleId><ArticleId IdType="pmc">PMC3798352</ArticleId><ArticleId IdType="pubmed">24173181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiewchengchol D, et al. Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. Rheumatology. 2014;53(8):1504&#x2013;1512. doi: 10.1093/rheumatology/keu137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu137</ArticleId><ArticleId IdType="pubmed">24692572</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Garc&#xed;a A, et al. Predictors of incident proteinuria among patients with SLE. Lupus Science &amp; Medicine. 2017;4(1):e000200. doi: 10.1136/lupus-2016-000200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000200</ArticleId><ArticleId IdType="pmc">PMC5691294</ArticleId><ArticleId IdType="pubmed">29177060</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Hern&#xe1;ndez J, et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med. 2004;116(3):165&#x2013;173. doi: 10.1016/j.amjmed.2003.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2003.08.034</ArticleId><ArticleId IdType="pubmed">14749160</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>